Dr. Omid Hamid from The Angeles Clinic goes over his favorite presentations coming up at ASCO 2024. Should these be…
Browsing: Immunotherapy
By. Anusha Kalbasi, MDDate. 11/22/2023In a recent discussion on adoptive T cell therapies for solid tumors, Anusha Kalbasi, MD, provided…
By. Bridget Keenan, MDDate. 11/22/2023Bridget Keenan, MD, discusses the tumor microenvironment (TME) and its crucial role in cancer immunotherapy responses.…
By. Anna M. Wu, MD, PhDDate. 11/21/2023Anna M. Wu, MD, PhD, discussed the use of immunotherapy in patients who underwent…
By. Kim Margolin, MDDate. 11/17/2023In the field of cancer immunotherapy, Kim Margolin, MD, provides insights into the interplay between the…
By. Mohamed H. Derbala, MDDate. October 31, 2023Mohamed H. Derbala, MD, an immuno-oncology expert and a Research Scientist at MD…
GeoVax, a pioneering healthcare company, has developed a groundbreaking product known as GADEPTIN. GADEPTIN is a cutting-edge therapy designed to…
Timothy Looney, PhD – Senior Director, Immunology and Bioinformatics at Singular Genomics By: Timothy Looney, PhD Date: 9/12/2023 The topic…
Philip McCarthy, MD, from Roswell Park Cancer Institute provided an overview of CAR T-cell therapy, focusing on its application in…
Gamma Delta: Two Phase 1 INDs Approved Announces Jeff Liter CEO Luminary Therapeutics By Jeff Liter, MBS, CEO of Luminary…
PRO in Pts With Rare Cancers: Pembrolizumab [2022] Â Patient reported Outcome (PRO) in patients with rare cancers (rare diseases)…
Follow real-world patients on their cancer journeys as they and their multidisciplinary clinical teams navigate barriers to receiving treatment with…
EXUMA Biotech’s VP of Oncology R&D, Dr. Sid Kerkar, Reveals Preclinical Data From Its Subcutaneous CAR-TaNK And In Vivo CAR…
Xianxin Hua, MD, Ph.D., Professor of Cancer Biology at the Abramson Cancer Research Institute, Department of Cancer Biology at the…
Xianxin Hua, MD, Ph.D., Professor of Cancer Biology at the Abramson Cancer Research Institute, Department of Cancer Biology at the…
Mehmet Altan, MD, Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center. In this video,…
Mehmet Altan, MD, Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center. In this video,…
Rebecca Harrison, MD, Assistant Professor of Neuro-Oncology at MD Anderson and is now a Clinical Associate Professor BC Cancer the…
Rebecca Harrison, MD, Assistant Professor of Neuro-Oncology at MD Anderson and is now a Clinical Associate Professor BC Cancer the…
Nazanin Majd, MD, Ph.D., BS, Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine at The University of Texas MD…
Nazanin Majd, MD, Ph.D., BS, Assistant Professor, Department of Neuro-Oncology, Division of Cancer Medicine at The University of Texas MD…
Augusto Villanueva, MD, Ph.D., Associate Professor, Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai (NY).…
Augusto Villanueva, MD, Ph.D., Associate Professor, Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai (NY).…
Peter Kim, MD, Associate Professor, Department of Cardiology, Division of Internal Medicine at MD Anderson Cancer Center. In this video,…
Bettzy Stephen, MBBS, MPH, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center. In this interview,…
Bettzy Stephen, MBBS, MPH, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center. In this interview,…
Alexis Combes, Ph.D., Director of Disease to Biology Colab at UCSF, Assistant professor department of pathology speaks about Sorting Cancers…
Alexis Combes, Ph.D., Director of Disease to Biology Colab at UCSF, Assistant professor department of pathology speaks about Sorting Cancers…
Yeonjoo Choi, MD from The Catholic University of Korea Incheon St. Mary’s Hospital speaks about T-cell Agonists In Cancer Immunotherapy.Link…
Hosts Jack West & Charu Aggarwal speak with immunotherapy expert Dr. Patrick Forde about unique advantages of the pre-operative platform…
Yeonjoo Choi, MD from The Catholic University of Korea Incheon St. Mary’s Hospital speaks about T-cell Agonists In Cancer Immunotherapy.Link…
Coya Tapia, MD, Ph.D., Surgical and Molecular Pathologist speaks about Decrease in tumor content assessed in biopsies is associated with…
Frederick L. Locke, MD from H. Lee Moffitt Cancer Center and Research Institute speaks about the Society for Immunotherapy of…
Synopsis: Â The most common symptom of cancer and its treatments is fatigue. In patients with chronic fatigue syndrome and…
Geoffrey M. Lowman, Ph.D. from Thermo Fisher Scientific discusses Haplotype Analysis of the T-Cell Receptor Beta (TCRB) Locus by Long-amplicon…
Tito R. Mendoza, Ph.D., MS, MEd from The University of Texas MD Anderson Cancer Center discusses Evaluating the psychometric properties…
Daniel Catenacci, MD of the University of Chicago Medicine discusses Gritstone Oncology Advances into Phase 2 Expansion Cohorts for its…
Jacob Adashek, DO of The University of South Florida and H. Lee Moffitt Cancer Center & Research Institute discusses the…
Jennifer Baker Flechtner, Ph.D. – Genocea Biosciences Inc’s Chief Scientific Officer discusses Genocea to Present Data that Reveal New Understanding…
Sigrun Hallmeyer, MD at ACCC discusses Immuno-Oncology and What Lies Ahead
Jacob J. Adashek, DO of Moffit Cancer Center gives an overview from ASCO 2020 the abstract entitled Targetable immune checkpoint…
Jared Gollob Chief Medical Officer @KymeraTx shares common questions he gets from colleagues such as “What’s Advantage of IRAK 4…
Jared Gollob @JaredGollob @KymeraTx gives an overview of a poster presented at AACR 2020 IRAKIMiD Degrader Program and Present Preclinical…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
John Williams, Ph.D. – City of Hope discusses Antibody based redirection of meditope CAR-T cells selectively kill antigen bearing tumor…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…
Daniel Spakowicz, PhD – The James – Ohio State University Comprehensive Cancer Center discusses Microbiome Might Reveal Whether Immune Therapy…